Basic Information
ID: ALA2447759
Type: Binding
Description: Inhibition of recombinant human CK2 using RRRDDDSDDD as substrate assessed as residual activity at 10 uM after 20 mins by beta counting analysis in presence of [gamma-labeled 32P]ATP relative to control
Organism: Homo sapiens
Activity Charts
Bioactivity
Activity Types for Assay ALA2447759
Activity
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 240.23 | 3.60 | 3.60 |
| 298.29 | 3.18 | 3.18 |
| 282.30 | 3.48 | 3.48 |
| 268.27 | 3.17 | 3.17 |
| 312.32 | 3.49 | 3.49 |
| 268.27 | 3.17 | 3.17 |
| 252.27 | 3.47 | 3.47 |
| 328.32 | 3.19 | 3.19 |
| 317.14 | 3.93 | 3.93 |
| 296.32 | 3.87 | 3.87 |
| 268.27 | 3.17 | 3.17 |
| 286.71 | 4.13 | 4.13 |
| 282.30 | 3.48 | 3.48 |
| 342.35 | 3.50 | 3.50 |
| 310.31 | 3.39 | 3.39 |
| 312.32 | 3.49 | 3.49 |
| 326.35 | 3.79 | 3.79 |
| 293.37 | 4.14 | 4.14 |
| 310.31 | 3.39 | 3.39 |
| 331.17 | 4.24 | 4.24 |
| 266.30 | 3.78 | 3.78 |
| 281.31 | 3.23 | 3.23 |
| 282.30 | 3.56 | 3.56 |
| 296.32 | 3.79 | 3.79 |
| 296.32 | 3.87 | 3.87 |
| 270.26 | 3.61 | 3.61 |
| 266.30 | 3.78 | 3.78 |
| 294.35 | 4.60 | 4.60 |
| 347.16 | 3.94 | 3.94 |
| 264.32 | 4.39 | 4.39 |
| 296.32 | 3.79 | 3.79 |
| 310.35 | 4.09 | 4.09 |
| 379.41 | 3.01 | 3.01 |
| 324.33 | 3.54 | 3.54 |
| 340.33 | 3.24 | 3.24 |
| 252.27 | 3.47 | 3.47 |
| 379.41 | 3.01 | 3.01 |
| 399.83 | 3.35 | 3.35 |
| 338.36 | 3.85 | 3.85 |
| 374.41 | 3.42 | 3.42 |
| 458.47 | 4.83 | 4.83 |
| 401.46 | 4.81 | 4.81 |
| 379.46 | 4.41 | 4.41 |
| 454.52 | 3.33 | 3.33 |
| 461.51 | 4.82 | 4.82 |
| 425.48 | 4.18 | 4.18 |
| 367.40 | 3.01 | 3.01 |
| 389.41 | 4.41 | 4.41 |
| 453.42 | 5.84 | 5.84 |
| 337.16 | 4.48 | 4.48 |
| 316.74 | 4.14 | 4.14 |
| 460.50 | 5.35 | 5.35 |
| 426.06 | 4.70 | 4.70 |